The ratings reflect UniMed’s very strong risk-adjusted capitalization, which results from the company’s low underwriting leverage, favorable liquidity and high quality of assets. In addition, UniMed has a good performance track record, with an average combined ratio of approximately 95% and a compounding annual growth rate in policyholders’ surplus of approximately 10% over a five-year period.
No comments:
Post a Comment